Catalyst
Slingshot members are tracking this event:
SAGE 547 May Not Go On Sale Until 2018 (Assuming FDA Approval; PDUFA Dec 19 2018)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SAGE |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 20, 2018
Occurred Source:
https://www.businesswire.com/news/home/20181120005168/en/Sage-Therapeutics-Receives-Notification-PDUFA-Extension-ZULRESSO%E2%84%A2
Related Projects
- Digesting the significance of SAGE-547's success in its Phase 2 postpartum depression study SAGE Executed On: Jul 29, 2016 at 12:45 PM EDT
Related Keywords
Sage-547, 2018, Commerical Launch
